Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Moderna
MRNA
|
$281M |
| 2 |
Amazon
AMZN
|
$231M |
| 3 |
Citizens Financial Group
CFG
|
$207M |
| 4 |
Apple
AAPL
|
$207M |
| 5 |
Amgen
AMGN
|
$196M |
Top Sells
Sector Composition
| 1 | Technology | 20.61% |
| 2 | Financials | 13.44% |
| 3 | Healthcare | 12.08% |
| 4 | Consumer Discretionary | 10.79% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
T-Mobile US
TMUS
$284B
| $365M | 0.12% |
2,855,760
+55,900
| +2% | +$7.14M |
|
152
Sherwin-Williams
SHW
$91.2B
| $363M | 0.12% |
1,297,849
+32,956
| +3% | +$9.22M |
|
153
SBA Communications
SBAC
$21B
| $360M | 0.12% |
1,087,651
+41,850
| +4% | +$13.8M |
|
154
Fidelity National Information Services
FIS
$35.9B
| $356M | 0.12% |
2,929,535
+246,405
| +9% | +$30M |
|
155
Tyson Foods
TSN
$20B
| $355M | 0.12% |
4,496,424
+172,745
| +4% | +$13.6M |
|
156
Chubb
CB
$112B
| $353M | 0.12% |
2,035,497
-25,577
| -1% | -$4.44M |
|
157
Best Buy
BBY
$16.3B
| $352M | 0.12% |
3,333,808
+217,101
| +7% | +$22.9M |
|
158
Cigna
CI
$81.2B
| $350M | 0.11% |
1,749,235
+28,417
| +2% | +$5.69M |
|
159
Marsh & McLennan
MMC
$101B
| $347M | 0.11% |
2,290,219
+15,656
| +0.7% | +$2.37M |
|
160
Schwab US REIT ETF
SCHH
$8.29B
| $345M | 0.11% |
15,108,512
+170,924
| +1% | +$3.9M |
|
161
Vanguard Mortgage-Backed Securities ETF
VMBS
$14.7B
| $341M | 0.11% |
6,401,297
+164,028
| +3% | +$8.74M |
|
162
Novartis
NVS
$249B
| $337M | 0.11% |
4,116,468
+38,337
| +0.9% | +$3.14M |
|
163
Estee Lauder
EL
$31.5B
| $333M | 0.11% |
1,109,841
+18,414
| +2% | +$5.52M |
|
164
Edwards Lifesciences
EW
$47.5B
| $333M | 0.11% |
2,938,697
+59,772
| +2% | +$6.77M |
|
165
International Paper
IP
$25.5B
| $325M | 0.11% |
6,146,701
+462,535
| +8% | +$24.5M |
|
166
Regions Financial
RF
$24.4B
| $325M | 0.11% |
15,262,774
+1,659,459
| +12% | +$35.4M |
|
167
Northern Trust
NTRS
$24.7B
| $323M | 0.11% |
2,997,478
+252,168
| +9% | +$27.2M |
|
168
Welltower
WELL
$112B
| $322M | 0.11% |
3,912,469
+115,586
| +3% | +$9.52M |
|
169
Ford
F
$46.5B
| $321M | 0.11% |
22,690,507
-794,334
| -3% | -$11.2M |
|
170
Regeneron Pharmaceuticals
REGN
$60.1B
| $320M | 0.1% |
529,528
+24,645
| +5% | +$14.9M |
|
171
Arthur J. Gallagher & Co
AJG
$77B
| $320M | 0.1% |
2,153,408
+4,511
| +0.2% | +$671K |
|
172
Boston Scientific
BSX
$159B
| $319M | 0.1% |
7,359,880
+709,180
| +11% | +$30.8M |
|
173
Fidelity MSCI Health Care Index ETF
FHLC
$2.46B
| $316M | 0.1% |
4,950,295
+58,473
| +1% | +$3.73M |
|
174
CSX Corp
CSX
$60.9B
| $313M | 0.1% |
10,534,592
+68,641
| +0.7% | +$2.04M |
|
175
Southern Company
SO
$101B
| $313M | 0.1% |
5,047,029
+80,550
| +2% | +$4.99M |
|